During first 24 months, 8.7% of patients with favorable pathological characteristics had progressed.
Women with stage IV bladder cancer have a lower median overall survival rate when compared to men.
About a quarter of older patients deemed too frail for chemo responded to atezolizumab.
Four key lifestyle factors include weight, exercise, no smoking, and limiting alcohol.
Atezolizumab received accelerated FDA approval for patients whose disease has progressed despite platinum-based chemotherapy.
Findings for self-reported leisure-time physical activity of moderate to vigorous intensity.
In a meta-analysis, men with benign prostatic hyperplasia had a 2.9 times and 1.7 times increased incidence of prostate cancer and bladder cancer, respectively.
Bladder cancer risk increases with longer duration of use.
Researchers found elevated incidences of upper tract urothelial carcinoma (UTUC) in patients with CKD.
Patients who underwent debulking had significantly longer overall survival compared with those who did not (median 15.7 vs 10 months).
Therapy used in less than 5% of cases, even in those with higher clinical stage.
Mortality risk decreases with increasingly stringent BPT compared with radical cystectomy.
This approach is associated with less need for blood transfusions versus open surgery, but short-term outcomes, including mortality, are similar.
African American survivors had lower intakes of 8 select micronutrients, such as folate, compared with Caucasian survivors.
The increased risk occurs more than 10 years after treatment and most pronounced in men who undergo brachytherapy.
Cancer-specific survival at 5 years was 76.9% for men and 71.5% for women.
New study also reveals no significant association between infection and use of proton pump inhibitors and peri-operative antibiotic redosing.
Researchers believe arsenic exposure might contribute to higher-than-normal rates.
The timing of office visits and telephone calls helped identify a patient at risk for readmission post-radical cystectomy.
Recommendations for diagnosing and managing non-muscle invasive bladder cancer promise to allow for more individualized patient care.
Shorter operating time is one advantage of cutaneous ureterostomy with a single stoma.
Median time to progression or drug discontinuation was 6.6 months in patients with specific genetic alterations, compared with 1.4 months in other patients.
Duration- and dose-response associations for pioglitazone; no correlation for rosiglitazone.
The guidelines were assessed for developmental rigor, and the ASCO endorsed all but one of the guidelines.
Vietnam veterans have an increased risk of bladder cancer and hypothyroidism due to exposure to Agent Orange.
Current smoking is independently associated with a greater than 2-fold increased odds of hospital readmission after radical cystectomy.
The more risk factors patients have, the greater their risk of serious perioperative complications.
Patients with venous thromboembolism tended to die earlier from their bladder cancer.
Exclusive rosiglitazone use is associated with 3-fold increased odds of bladder cancer.
The likelihood of being diagnosed with the malignancy was 37% lower in men who used the 5ɑ-reductase inhibitor than those who did.
- Blacks With Diabetes and CKD Have Higher CVD Risk
- Worse Re-transplant Outcomes for HIV Positive Patients
- Race, Procedure Type Influence Morbidity in Pediatric Surgery Patients
- Parathyroidectomy Rates Stable Despite Changes in Medical Therapy
- Early Recurrence After Laparoscopic Radical Cystectomy Explored
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)